Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches

This study expands on previous analyses of economic benefits from vaccines from 73 to 94 countries and extends the time horizon to include the future decade, 2021 to 2030.

Auteurs